Labelling
46.—(1) An investigational medicinal product shall be labelled in accordance with Article 15 of Commission Directive 2003/94/EC(a).
(2) Paragraph (1) shall not apply where the investigational medicinal product is—
(a) for use in a clinical trial with the characteristics specified in the second paragraph of Article 14 of the Directive;
(b) dispensed to a subject in accordance with a prescription given by an authorised health care professional; and
(c) labelled in accordance with the requirements of Schedule 5 to the Medicines for Human Use (Marketing Authorisations Etc.) Regulations 1994(b) that apply in relation to dispensed relevant medicinal products.